Catalyst Wire Dossier Catalyst Wire Dossier

ION-827359

· Ionis Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ION-827359, covering 2022-12-20 to 2022-12-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB) [Phase 2]

See pricing